Work

P023 Impact of lumacaftor/ivacaftor (Orkambi®) on proton pump inhibitor use in adult cystic fibrosis patients

Year: 2018

Type: conference-abstract

Source: Journal of Cystic Fibrosis

DOI: 10.1016/s1569-1993(18)30320-5

Authors: A. Connolly, M. Moran, C. Keane, E. Mckone, C. Gallagher

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2807658615

Cites:

Cited by:

Related to: 10